CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that management will present at two upcoming conferences:
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that management will present at two upcoming conferences:
